Research Triangle Park, NC2 Active Studies

Myositis Clinical Trials in Research Triangle Park, NC

Find 2 actively recruiting myositis clinical trials in Research Triangle Park, NC. Connect with local research sites and explore new treatment options.

2
Active Trials
1
Sponsors
1,780
Enrolling

Recruiting Myositis Studies in Research Triangle Park

About Myositis Clinical Trials in Research Triangle Park

Myositis refers to inflammatory conditions causing muscle weakness and inflammation. Dermatomyositis also involves skin rashes, while polymyositis primarily affects muscles closest to the trunk. Treatment includes corticosteroids, immunosuppressants, and physical therapy.

There are currently 2 myositis clinical trials recruiting participants in Research Triangle Park, NC. These studies are seeking a combined 1,780 participants. Research is being sponsored by National Institute of Environmental Health Sciences (NIEHS). Clinical trial participation is free and participants receive study-related medical care at no cost.

Myositis Clinical Trials in Research Triangle Park — FAQ

Are there myositis clinical trials in Research Triangle Park?

Yes, there are 2 myositis clinical trials currently recruiting in Research Triangle Park, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Research Triangle Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Research Triangle Park research site will contact you about next steps.

Are clinical trials in Research Triangle Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Research Triangle Park studies also compensate for your time and travel.

What myositis treatments are being tested?

The 2 active trials in Research Triangle Park are testing new therapies including novel drugs, biologics, and treatment approaches for myositis.

Data updated July 13, 2026 from ClinicalTrials.gov